Data · dataset · 2026
<p>A subpopulation of effector CD4<sup>+</sup> T cells is primarily responsible for reactivity to immunogenic <i>Francisella</i> epitopes.</p>
Listed in ZivaHub
Description
<p>C57Bl/6 mice were injected subcutaneously with either 3 × 10<sup>4</sup> CFU of <i>F. tularensis</i> LVS (immune) or sterile PBS (control), and lymphocytes were isolated 3 weeks later and pooled from groups of 4 mice. Cocultures of 3 × 10<sup>5</sup> splenic CD4<sup>+</sup> T cells and 2 × 10<sup>5</sup> naïve B cells were stimulated for 24 h with a mixture of 5 selected immunogenic peptides (PP-4) (Table B in <a href="plospathogens.org/article/info:doi/10.1371/journal.ppat.1014597#ppat.1014597.s002" target="_blank">S1 Appendix</a>) or left without peptides (unstim) and the IFN-γ response was determined.
A concentration of 5 µM was used for each peptide. (A) The numbers of IFN-γ producing cells (SFCs) were determined using ELISpot. Furthermore, the % of intracellular IFN-γ-positive cells among live (B) total CD4<sup>+</sup> T cells or (C) subpopulation of CD4<sup>+</sup>CD62L<sup>-</sup>CD44<sup>+</sup> effector T cells was determined by FACS analysis.
Read the rest (2 more)
Each dot represents one technical replicate and mean values are shown. Differences between groups were determined with two-way ANOVA followed by Tukey’s post hoc test. Asterisks indicate p-values (****p < 0.0001).
Peptide YAIAVNDLGTEYVHR (mouse Gls) was used as a negative peptide (negative). Data are combined results of two biological replicates.</p>
Links
Where it is published
- DOI doi.org/10.1371/journal.ppat.1014597.g005 ↗
DOI / persistent id · from zivahub uct ac za
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from zivahub uct ac za
Topics
- From keywords
- Biochemistry and cell biology · Cancer · Earth & Environmental Science · Immunology · Infectious diseases · Life Sciences · Medicine & Health · Microbiology
- Inferred from text
- Tabular 65%
Provenance · 1 source records, 14 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| ZivaHub | oai:figshare.com:article/34026931 | 10 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[disease].local:disease:cancer | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Cancer'] |
| concepts[field].anzsrc:field:320211 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Infectious Diseases'] |
| concepts[field].anzsrc:group:3101 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Cell Biology'] |
| concepts[field].anzsrc:group:3107 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Microbiology'] |
| concepts[field].anzsrc:group:3204 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Immunology'] |
| concepts[field].local:field:earth-environmental | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:life-sciences | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[modality].local:modality:tabular | enrichment · zivahub uct ac za | keyword-concept-rules@1.0.0 | title+description (65%) |
| description | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/description |
| license | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/rights |
| publication_date | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| title | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/title |